CIK 0001341235
- Non-accelerated filer
- Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- Open-market buys, last 90 days
- $140,275
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$140,275. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-06 | Clark David J Chief Medical Officer | Purchase | +5,000 | $5.06 | $25K | 17,878 |
| 2019-03-05 | Clark David J Chief Medical Officer | Grant or award | +3,503 | 11,512 | ||
| 2019-03-05 | Clark David J Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2018-03-06 | Clark David J Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +108,633 | 108,633 | ||
| 2017-12-29 | Clark David J Chief Medical Officer | Grant or award | +4,774 | $4.00 | $19K | 4,774 |
| 2017-03-03 | Clark David J Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +155,656 | 155,656 | ||
| 2016-01-11 | Clark David J Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 1 of 1 · 7 trades